About MetroHealth CRS (2503)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at MetroHealth CRS (2503)
During the past decade, MetroHealth CRS (2503) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MetroHealth CRS (2503)"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MetroHealth CRS (2503)
According to Clinical.Site data, the most researched conditions in "MetroHealth CRS (2503)" are
"HIV Infections" (3 trials) and "HIV-1 Infection" (1 trials). Many other conditions were trialed in "MetroHealth CRS (2503)" in a lesser frequency.
Clinical Trials Intervention Types at MetroHealth CRS (2503)
Most popular intervention types in "MetroHealth CRS (2503)" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Calcium Carbonate" (1 trials), "Chloroquine" (1 trials), "EFV/FTC/TDF" (1 trials), "Maraviroc" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MetroHealth CRS (2503)
The vast majority of trials in "MetroHealth CRS (2503)" are
4 trials for "All" genders.
Clinical Trials Status at MetroHealth CRS (2503)
Currently, there are NaN active trials in "MetroHealth CRS (2503)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in MetroHealth CRS (2503),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MetroHealth CRS (2503), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".